Key Insights
The Global Blood Testing Market is projected to witness robust growth, reaching a substantial size of USD 90.62 million in 2025. This expansion is fueled by an estimated Compound Annual Growth Rate (CAGR) of 6.88% throughout the forecast period of 2025-2033. The market's dynamism is driven by several critical factors. An increasing prevalence of chronic diseases, coupled with a growing emphasis on early disease detection and preventative healthcare, serves as a primary catalyst. Advancements in diagnostic technologies, leading to more accurate, faster, and less invasive blood testing methods, further bolster market expansion. The rising disposable incomes in emerging economies are also contributing to increased healthcare expenditure and demand for advanced diagnostic services. Furthermore, the ongoing COVID-19 pandemic has significantly highlighted the importance of rapid and accessible diagnostic testing, creating a sustained demand for blood testing solutions. The integration of automation and artificial intelligence in blood testing workflows is enhancing efficiency and accuracy, thereby driving market adoption.
Global Blood Testing Market Market Size (In Million)
The market is segmented across various testing types, with Glucose Testing and Lipid Panel Testing likely dominating due to the high incidence of diabetes and cardiovascular diseases globally. Prostate Specific Antigen (PSA) Testing and Thyroid Stimulating Hormone (TSH) Testing are also expected to show significant growth driven by aging populations and increasing health awareness. In terms of methods, Automated Blood Testing is poised to outperform Manual Blood Testing due to its speed, precision, and reduced risk of human error, especially within high-throughput settings. Key end-users like Diagnostic Laboratories and Hospitals are the primary revenue generators, owing to their extensive infrastructure and patient outreach. The geographical landscape indicates strong market presence in North America and Europe, driven by established healthcare systems and technological adoption. However, the Asia Pacific region is anticipated to exhibit the highest growth rate, propelled by expanding healthcare infrastructure, a burgeoning middle class, and increasing awareness of health and wellness. Strategic initiatives by leading companies such as Abbott Laboratories, F Hoffmann-La Roche AG, and Thermo Fisher Scientific in research and development, along with mergers and acquisitions, are expected to shape the competitive landscape and drive innovation.
Global Blood Testing Market Company Market Share
Here's a compelling, SEO-optimized report description for the Global Blood Testing Market:
Global Blood Testing Market Report: Size, Trends, Forecast 2025-2033 | Leading Players, Segments, and Opportunities
This comprehensive Global Blood Testing Market report offers an in-depth analysis of the market's dynamics, growth trends, and future outlook. Covering the historical period from 2019–2024 and forecasting through 2033, with a base year of 2025, this research provides critical insights for stakeholders. We meticulously examine market size evolution, technological advancements, regulatory landscapes, and competitive strategies, highlighting key drivers, barriers, and emerging opportunities. The report delivers actionable intelligence on dominant regions, countries, and segments, including detailed segmentation by Type (Glucose Testing, Lipid Panel Testing, Prostate Specific Antigen (PSA) Testing, Blood Urea Nitrogen (BUN) Testing, Thyroid Stimulating Hormone Testing, Others), Methods (Manual Blood Testing, Automated Blood Testing), and End User (Diagnostic Laboratories, Hospitals, Other End Users). Discover how leading companies like Abbott Laboratories, Thermo Fisher Scientific, and F. Hoffmann-La Roche AG are shaping the future of blood diagnostics.
Global Blood Testing Market Market Dynamics & Structure
The global blood testing market exhibits a moderately concentrated structure, with a few key players holding significant market share, alongside a growing number of innovative smaller companies. Technological innovation is a primary driver, fueled by advancements in molecular diagnostics, automation, and point-of-care testing. Regulatory frameworks, such as FDA approvals and CLIA certifications, play a crucial role in market access and product development, creating both opportunities and barriers. The competitive landscape is shaped by the availability of advanced diagnostic tools and the ongoing development of more accurate and less invasive blood tests, acting as competitive substitutes for traditional methods. End-user demographics, including an aging global population and increasing prevalence of chronic diseases, are significantly influencing demand. Mergers and acquisitions (M&A) are a notable trend, with companies consolidating to expand their product portfolios, geographic reach, and technological capabilities. For instance, the past five years have seen at least XX significant M&A deals, valued at over $XXX million, aimed at acquiring innovative technologies or expanding market presence.
- Market Concentration: Characterized by a blend of large, established players and agile emerging companies, with a trend towards consolidation.
- Technological Innovation Drivers: Driven by advancements in areas like liquid biopsy, microfluidics, and AI-powered data analysis.
- Regulatory Frameworks: Stringent but essential for ensuring accuracy, safety, and efficacy, impacting R&D cycles and market entry.
- Competitive Product Substitutes: Continuous innovation in areas like imaging and genetic testing offers alternative diagnostic pathways, pushing blood testing to evolve.
- End-User Demographics: Growing demand from aging populations and the increasing burden of chronic diseases such as diabetes, cardiovascular diseases, and cancer.
- M&A Trends: Strategic acquisitions and partnerships are common for expanding portfolios, gaining market share, and accessing new technologies.
Global Blood Testing Market Growth Trends & Insights
The global blood testing market is poised for significant expansion, driven by an escalating global demand for accurate and accessible diagnostic solutions. The market size is projected to grow from an estimated $XX,XXX million in 2025 to $XX,XXX million by 2033, demonstrating a robust Compound Annual Growth Rate (CAGR) of approximately XX% during the forecast period (2025–2033). This growth is underpinned by several key trends, including the increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, which necessitate regular blood monitoring. Furthermore, the rising awareness among individuals regarding preventive healthcare and the early detection of diseases is propelling the adoption of routine blood tests. Technological disruptions are also playing a pivotal role, with the development of advanced automated blood testing systems that offer enhanced speed, accuracy, and efficiency, and the emergence of novel biomarker discovery and liquid biopsy techniques revolutionizing cancer diagnostics and monitoring.
Consumer behavior is shifting towards personalized medicine and proactive health management, leading to a greater demand for comprehensive blood panels and genetic testing. The integration of artificial intelligence (AI) and machine learning (ML) in analyzing blood test results is further enhancing diagnostic capabilities, allowing for more precise interpretations and predictive insights. The expansion of healthcare infrastructure in emerging economies and favorable government initiatives supporting diagnostics are also contributing to market penetration. The increasing investment in research and development by both established and new market players is fostering a pipeline of innovative blood testing solutions, from rapid point-of-care tests to sophisticated molecular diagnostics. The market penetration for essential blood tests like glucose and lipid panels is already high in developed regions, but growth opportunities lie in expanding access to advanced tests and in underserved populations globally. The ongoing evolution of diagnostic technologies, coupled with a growing emphasis on early disease detection and personalized treatment approaches, will continue to fuel the upward trajectory of the global blood testing market.
Dominant Regions, Countries, or Segments in Global Blood Testing Market
The North America region is currently the dominant force in the global blood testing market, driven by a confluence of factors that foster innovation, adoption, and demand. The region boasts a highly developed healthcare infrastructure, significant investment in research and development, and a well-established reimbursement system that supports the utilization of advanced blood testing technologies. The presence of leading pharmaceutical and biotechnology companies, coupled with a high prevalence of chronic diseases and an aging population, further fuels market growth. Within North America, the United States stands out as the leading country, accounting for a substantial share of the global market due to its advanced healthcare systems, extensive network of diagnostic laboratories, and a strong emphasis on preventive healthcare.
In terms of segments, Glucose Testing is a consistently high-volume and dominant category within the Type segmentation. This is directly attributable to the global epidemic of diabetes and prediabetes, requiring frequent monitoring for effective management. The market size for glucose testing alone is estimated to be over $XX,XXX million in 2025. The Automated Blood Testing method segment also holds significant dominance, reflecting the shift towards laboratory efficiency, reduced manual errors, and higher throughput in diagnostic settings. Automated systems offer substantial advantages in terms of speed and accuracy, making them the preferred choice for high-volume testing in hospitals and large diagnostic laboratories. Consequently, Diagnostic Laboratories and Hospitals emerge as the dominant end-user segments, representing the primary consumers of blood testing services and technologies. These facilities are equipped to handle the complex workflow of blood sample processing and analysis, driving innovation and market demand for sophisticated instrumentation and reagents. The growth potential within these dominant segments is sustained by ongoing technological advancements and the continuous need for accurate disease diagnosis and management.
- Dominant Region: North America, spearheaded by the United States, due to advanced healthcare infrastructure, R&D investment, and high disease prevalence.
- Dominant Country: United States, leading in market share due to its comprehensive healthcare ecosystem and strong diagnostic capabilities.
- Dominant Segment (Type): Glucose Testing, driven by the global diabetes epidemic and the necessity for continuous patient monitoring.
- Dominant Segment (Method): Automated Blood Testing, favored for its efficiency, accuracy, and ability to handle high testing volumes.
- Dominant End User: Diagnostic Laboratories and Hospitals, which are the primary hubs for blood sample collection, processing, and analysis, driving demand for advanced technologies and services.
Global Blood Testing Market Product Landscape
The global blood testing market is characterized by continuous product innovation, aiming to enhance diagnostic accuracy, speed, and accessibility. Key advancements include the development of highly sensitive immunoassays for early disease detection, sophisticated molecular diagnostic platforms for genetic analysis, and the proliferation of point-of-care (POC) testing devices that enable rapid results at the patient's bedside. Innovations in automation have led to fully integrated laboratory systems that streamline workflows and minimize human error. Furthermore, the development of novel biomarkers and the expansion of liquid biopsy technologies are transforming cancer diagnostics, allowing for non-invasive tumor detection and monitoring. These products exhibit superior performance metrics, including higher sensitivity, specificity, and reduced turnaround times, setting new benchmarks in diagnostic capabilities and offering unique selling propositions in a competitive market.
Key Drivers, Barriers & Challenges in Global Blood Testing Market
The global blood testing market is propelled by several key drivers, including the escalating prevalence of chronic diseases worldwide, such as diabetes, cardiovascular disorders, and various cancers, which necessitate regular blood monitoring. Technological advancements, particularly in automation, molecular diagnostics, and point-of-care testing, are enhancing accuracy, speed, and accessibility, thereby driving market growth. The increasing emphasis on preventive healthcare and early disease detection among individuals further fuels demand for routine blood tests. Favorable government initiatives and rising healthcare expenditure in emerging economies also contribute significantly.
However, the market faces several challenges and restraints. High development costs for advanced diagnostic technologies and stringent regulatory approval processes can be significant barriers to entry for new players. Issues related to reimbursement policies and pricing pressures from healthcare providers can also impact market growth. Supply chain disruptions for critical reagents and components, exacerbated by geopolitical events, pose a considerable risk. Moreover, the need for skilled personnel to operate and interpret complex diagnostic equipment remains a challenge in certain regions. Competitive pressures from alternative diagnostic methods and the increasing complexity of diseases requiring multi-analyte testing also present hurdles.
Emerging Opportunities in Global Blood Testing Market
Emerging opportunities within the global blood testing market lie in the expansion of liquid biopsy technologies for non-invasive cancer screening and monitoring, offering significant potential for early detection and personalized treatment strategies. The growing demand for point-of-care (POC) testing solutions, particularly in remote or underserved areas, presents a substantial growth avenue, enabling rapid diagnosis and immediate treatment decisions. The integration of artificial intelligence (AI) and machine learning (ML) for enhanced data analysis and predictive diagnostics offers innovative applications that can improve accuracy and efficiency. Furthermore, the burgeoning field of microbiome analysis through blood testing presents an untapped market with potential for diagnosing and managing a wide range of conditions. The increasing focus on personalized medicine and companion diagnostics also opens doors for highly specific blood tests tailored to individual patient profiles.
Growth Accelerators in the Global Blood Testing Market Industry
Several growth accelerators are poised to propel the global blood testing market forward. Technological breakthroughs in areas like microfluidics, biosensors, and advanced immunoassay development are enabling the creation of more sensitive, specific, and cost-effective diagnostic tools. Strategic partnerships and collaborations between diagnostic companies, research institutions, and pharmaceutical firms are fostering innovation and accelerating the translation of research into marketable products. Market expansion strategies, including entering emerging economies with growing healthcare needs and developing tailored solutions for specific diseases, are crucial growth drivers. The increasing adoption of automated laboratory systems and the development of integrated diagnostic platforms are also streamlining workflows and enhancing overall laboratory efficiency, contributing to sustained market expansion.
Key Players Shaping the Global Blood Testing Market Market
- Abbott Laboratories
- Thermo Fisher Scientific
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Becton Dickinson and Company
- Bio-Rad Laboratories
- Siemens Healthineers
- bioMérieux SA
- Sysmex Corporation
- PerkinElmer Inc.
- QIAGEN N.V.
- Waters Corporation
- Shimadzu Corporation
- Novartis International AG
- Una Health Ltd
Notable Milestones in Global Blood Testing Market Sector
- March 2023: Guardant Health, Inc. submitted to the US Food and Drug Administration (FDA) the final module of its premarket approval (PMA) application for Shield, Guardant Health's blood test to screen for colorectal cancer (CRC).
- December 2022: Gurugram-based startup PredOmix unveiled an innovative cancer detection blood test, OncoVeryx-F. It can detect early-stage cancers in women with a 98% accuracy.
In-Depth Global Blood Testing Market Market Outlook
The future outlook for the global blood testing market is exceptionally promising, driven by persistent advancements in diagnostic technologies and a growing global emphasis on proactive health management. Growth accelerators, including the expansion of liquid biopsy for non-invasive diagnostics and the increasing demand for rapid point-of-care testing, will continue to shape market dynamics. Strategic partnerships and the development of AI-integrated diagnostic platforms are expected to further enhance accuracy and efficiency. Emerging markets, coupled with favorable healthcare policies, represent significant untapped potential. The market is poised for sustained growth, offering substantial opportunities for innovation and investment in solutions that improve disease detection, patient outcomes, and overall public health worldwide.
Global Blood Testing Market Segmentation
-
1. Type
- 1.1. Glucose Testing
- 1.2. Lipid Panel Testing
- 1.3. Prostate Specific Antigen (PSA) Testing
- 1.4. Blood Urea Nitrogen (BUN) Testing
- 1.5. Thyroid Stimulating Hormone Testing
- 1.6. Other Ty
-
2. Methods
- 2.1. Manual Blood Testing
- 2.2. Automated Blood Testing
-
3. End User
- 3.1. Diagnostic Laboratories
- 3.2. Hospitals
- 3.3. Other End Users
Global Blood Testing Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Global Blood Testing Market Regional Market Share
Geographic Coverage of Global Blood Testing Market
Global Blood Testing Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 6.88% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Burden of Chronic Diseases; Rising Demand for Home Healthcare and the Introduction of Advance Technology-enabled Products; Implementation of Favorable Government Initiatives & External Funding for R&D Exercises
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Approval Process
- 3.4. Market Trends
- 3.4.1. Glucose Testing is Expected to Hold Significant Share of the Blood Testing Market.
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Blood Testing Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Glucose Testing
- 5.1.2. Lipid Panel Testing
- 5.1.3. Prostate Specific Antigen (PSA) Testing
- 5.1.4. Blood Urea Nitrogen (BUN) Testing
- 5.1.5. Thyroid Stimulating Hormone Testing
- 5.1.6. Other Ty
- 5.2. Market Analysis, Insights and Forecast - by Methods
- 5.2.1. Manual Blood Testing
- 5.2.2. Automated Blood Testing
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Diagnostic Laboratories
- 5.3.2. Hospitals
- 5.3.3. Other End Users
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America Global Blood Testing Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. Glucose Testing
- 6.1.2. Lipid Panel Testing
- 6.1.3. Prostate Specific Antigen (PSA) Testing
- 6.1.4. Blood Urea Nitrogen (BUN) Testing
- 6.1.5. Thyroid Stimulating Hormone Testing
- 6.1.6. Other Ty
- 6.2. Market Analysis, Insights and Forecast - by Methods
- 6.2.1. Manual Blood Testing
- 6.2.2. Automated Blood Testing
- 6.3. Market Analysis, Insights and Forecast - by End User
- 6.3.1. Diagnostic Laboratories
- 6.3.2. Hospitals
- 6.3.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. Europe Global Blood Testing Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. Glucose Testing
- 7.1.2. Lipid Panel Testing
- 7.1.3. Prostate Specific Antigen (PSA) Testing
- 7.1.4. Blood Urea Nitrogen (BUN) Testing
- 7.1.5. Thyroid Stimulating Hormone Testing
- 7.1.6. Other Ty
- 7.2. Market Analysis, Insights and Forecast - by Methods
- 7.2.1. Manual Blood Testing
- 7.2.2. Automated Blood Testing
- 7.3. Market Analysis, Insights and Forecast - by End User
- 7.3.1. Diagnostic Laboratories
- 7.3.2. Hospitals
- 7.3.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Asia Pacific Global Blood Testing Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. Glucose Testing
- 8.1.2. Lipid Panel Testing
- 8.1.3. Prostate Specific Antigen (PSA) Testing
- 8.1.4. Blood Urea Nitrogen (BUN) Testing
- 8.1.5. Thyroid Stimulating Hormone Testing
- 8.1.6. Other Ty
- 8.2. Market Analysis, Insights and Forecast - by Methods
- 8.2.1. Manual Blood Testing
- 8.2.2. Automated Blood Testing
- 8.3. Market Analysis, Insights and Forecast - by End User
- 8.3.1. Diagnostic Laboratories
- 8.3.2. Hospitals
- 8.3.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Middle East and Africa Global Blood Testing Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. Glucose Testing
- 9.1.2. Lipid Panel Testing
- 9.1.3. Prostate Specific Antigen (PSA) Testing
- 9.1.4. Blood Urea Nitrogen (BUN) Testing
- 9.1.5. Thyroid Stimulating Hormone Testing
- 9.1.6. Other Ty
- 9.2. Market Analysis, Insights and Forecast - by Methods
- 9.2.1. Manual Blood Testing
- 9.2.2. Automated Blood Testing
- 9.3. Market Analysis, Insights and Forecast - by End User
- 9.3.1. Diagnostic Laboratories
- 9.3.2. Hospitals
- 9.3.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. South America Global Blood Testing Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Type
- 10.1.1. Glucose Testing
- 10.1.2. Lipid Panel Testing
- 10.1.3. Prostate Specific Antigen (PSA) Testing
- 10.1.4. Blood Urea Nitrogen (BUN) Testing
- 10.1.5. Thyroid Stimulating Hormone Testing
- 10.1.6. Other Ty
- 10.2. Market Analysis, Insights and Forecast - by Methods
- 10.2.1. Manual Blood Testing
- 10.2.2. Automated Blood Testing
- 10.3. Market Analysis, Insights and Forecast - by End User
- 10.3.1. Diagnostic Laboratories
- 10.3.2. Hospitals
- 10.3.3. Other End Users
- 10.1. Market Analysis, Insights and Forecast - by Type
- 11. Competitive Analysis
- 11.1. Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Becton Dickinson and Company
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 BioMerieux SA
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Novartis International AG
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Waters Corporation
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Una Health Ltd
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Abbott Laboratories
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Danaher Corporation
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 F Hoffmann-La Roche AG
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 BioRad Laboratories
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Thermo Fisher Scientific
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 PerkinElmer Inc
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Shimadzu Corporation
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: Global Global Blood Testing Market Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: Global Global Blood Testing Market Volume Breakdown (K Unit, %) by Region 2025 & 2033
- Figure 3: North America Global Blood Testing Market Revenue (Million), by Type 2025 & 2033
- Figure 4: North America Global Blood Testing Market Volume (K Unit), by Type 2025 & 2033
- Figure 5: North America Global Blood Testing Market Revenue Share (%), by Type 2025 & 2033
- Figure 6: North America Global Blood Testing Market Volume Share (%), by Type 2025 & 2033
- Figure 7: North America Global Blood Testing Market Revenue (Million), by Methods 2025 & 2033
- Figure 8: North America Global Blood Testing Market Volume (K Unit), by Methods 2025 & 2033
- Figure 9: North America Global Blood Testing Market Revenue Share (%), by Methods 2025 & 2033
- Figure 10: North America Global Blood Testing Market Volume Share (%), by Methods 2025 & 2033
- Figure 11: North America Global Blood Testing Market Revenue (Million), by End User 2025 & 2033
- Figure 12: North America Global Blood Testing Market Volume (K Unit), by End User 2025 & 2033
- Figure 13: North America Global Blood Testing Market Revenue Share (%), by End User 2025 & 2033
- Figure 14: North America Global Blood Testing Market Volume Share (%), by End User 2025 & 2033
- Figure 15: North America Global Blood Testing Market Revenue (Million), by Country 2025 & 2033
- Figure 16: North America Global Blood Testing Market Volume (K Unit), by Country 2025 & 2033
- Figure 17: North America Global Blood Testing Market Revenue Share (%), by Country 2025 & 2033
- Figure 18: North America Global Blood Testing Market Volume Share (%), by Country 2025 & 2033
- Figure 19: Europe Global Blood Testing Market Revenue (Million), by Type 2025 & 2033
- Figure 20: Europe Global Blood Testing Market Volume (K Unit), by Type 2025 & 2033
- Figure 21: Europe Global Blood Testing Market Revenue Share (%), by Type 2025 & 2033
- Figure 22: Europe Global Blood Testing Market Volume Share (%), by Type 2025 & 2033
- Figure 23: Europe Global Blood Testing Market Revenue (Million), by Methods 2025 & 2033
- Figure 24: Europe Global Blood Testing Market Volume (K Unit), by Methods 2025 & 2033
- Figure 25: Europe Global Blood Testing Market Revenue Share (%), by Methods 2025 & 2033
- Figure 26: Europe Global Blood Testing Market Volume Share (%), by Methods 2025 & 2033
- Figure 27: Europe Global Blood Testing Market Revenue (Million), by End User 2025 & 2033
- Figure 28: Europe Global Blood Testing Market Volume (K Unit), by End User 2025 & 2033
- Figure 29: Europe Global Blood Testing Market Revenue Share (%), by End User 2025 & 2033
- Figure 30: Europe Global Blood Testing Market Volume Share (%), by End User 2025 & 2033
- Figure 31: Europe Global Blood Testing Market Revenue (Million), by Country 2025 & 2033
- Figure 32: Europe Global Blood Testing Market Volume (K Unit), by Country 2025 & 2033
- Figure 33: Europe Global Blood Testing Market Revenue Share (%), by Country 2025 & 2033
- Figure 34: Europe Global Blood Testing Market Volume Share (%), by Country 2025 & 2033
- Figure 35: Asia Pacific Global Blood Testing Market Revenue (Million), by Type 2025 & 2033
- Figure 36: Asia Pacific Global Blood Testing Market Volume (K Unit), by Type 2025 & 2033
- Figure 37: Asia Pacific Global Blood Testing Market Revenue Share (%), by Type 2025 & 2033
- Figure 38: Asia Pacific Global Blood Testing Market Volume Share (%), by Type 2025 & 2033
- Figure 39: Asia Pacific Global Blood Testing Market Revenue (Million), by Methods 2025 & 2033
- Figure 40: Asia Pacific Global Blood Testing Market Volume (K Unit), by Methods 2025 & 2033
- Figure 41: Asia Pacific Global Blood Testing Market Revenue Share (%), by Methods 2025 & 2033
- Figure 42: Asia Pacific Global Blood Testing Market Volume Share (%), by Methods 2025 & 2033
- Figure 43: Asia Pacific Global Blood Testing Market Revenue (Million), by End User 2025 & 2033
- Figure 44: Asia Pacific Global Blood Testing Market Volume (K Unit), by End User 2025 & 2033
- Figure 45: Asia Pacific Global Blood Testing Market Revenue Share (%), by End User 2025 & 2033
- Figure 46: Asia Pacific Global Blood Testing Market Volume Share (%), by End User 2025 & 2033
- Figure 47: Asia Pacific Global Blood Testing Market Revenue (Million), by Country 2025 & 2033
- Figure 48: Asia Pacific Global Blood Testing Market Volume (K Unit), by Country 2025 & 2033
- Figure 49: Asia Pacific Global Blood Testing Market Revenue Share (%), by Country 2025 & 2033
- Figure 50: Asia Pacific Global Blood Testing Market Volume Share (%), by Country 2025 & 2033
- Figure 51: Middle East and Africa Global Blood Testing Market Revenue (Million), by Type 2025 & 2033
- Figure 52: Middle East and Africa Global Blood Testing Market Volume (K Unit), by Type 2025 & 2033
- Figure 53: Middle East and Africa Global Blood Testing Market Revenue Share (%), by Type 2025 & 2033
- Figure 54: Middle East and Africa Global Blood Testing Market Volume Share (%), by Type 2025 & 2033
- Figure 55: Middle East and Africa Global Blood Testing Market Revenue (Million), by Methods 2025 & 2033
- Figure 56: Middle East and Africa Global Blood Testing Market Volume (K Unit), by Methods 2025 & 2033
- Figure 57: Middle East and Africa Global Blood Testing Market Revenue Share (%), by Methods 2025 & 2033
- Figure 58: Middle East and Africa Global Blood Testing Market Volume Share (%), by Methods 2025 & 2033
- Figure 59: Middle East and Africa Global Blood Testing Market Revenue (Million), by End User 2025 & 2033
- Figure 60: Middle East and Africa Global Blood Testing Market Volume (K Unit), by End User 2025 & 2033
- Figure 61: Middle East and Africa Global Blood Testing Market Revenue Share (%), by End User 2025 & 2033
- Figure 62: Middle East and Africa Global Blood Testing Market Volume Share (%), by End User 2025 & 2033
- Figure 63: Middle East and Africa Global Blood Testing Market Revenue (Million), by Country 2025 & 2033
- Figure 64: Middle East and Africa Global Blood Testing Market Volume (K Unit), by Country 2025 & 2033
- Figure 65: Middle East and Africa Global Blood Testing Market Revenue Share (%), by Country 2025 & 2033
- Figure 66: Middle East and Africa Global Blood Testing Market Volume Share (%), by Country 2025 & 2033
- Figure 67: South America Global Blood Testing Market Revenue (Million), by Type 2025 & 2033
- Figure 68: South America Global Blood Testing Market Volume (K Unit), by Type 2025 & 2033
- Figure 69: South America Global Blood Testing Market Revenue Share (%), by Type 2025 & 2033
- Figure 70: South America Global Blood Testing Market Volume Share (%), by Type 2025 & 2033
- Figure 71: South America Global Blood Testing Market Revenue (Million), by Methods 2025 & 2033
- Figure 72: South America Global Blood Testing Market Volume (K Unit), by Methods 2025 & 2033
- Figure 73: South America Global Blood Testing Market Revenue Share (%), by Methods 2025 & 2033
- Figure 74: South America Global Blood Testing Market Volume Share (%), by Methods 2025 & 2033
- Figure 75: South America Global Blood Testing Market Revenue (Million), by End User 2025 & 2033
- Figure 76: South America Global Blood Testing Market Volume (K Unit), by End User 2025 & 2033
- Figure 77: South America Global Blood Testing Market Revenue Share (%), by End User 2025 & 2033
- Figure 78: South America Global Blood Testing Market Volume Share (%), by End User 2025 & 2033
- Figure 79: South America Global Blood Testing Market Revenue (Million), by Country 2025 & 2033
- Figure 80: South America Global Blood Testing Market Volume (K Unit), by Country 2025 & 2033
- Figure 81: South America Global Blood Testing Market Revenue Share (%), by Country 2025 & 2033
- Figure 82: South America Global Blood Testing Market Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Blood Testing Market Revenue Million Forecast, by Type 2020 & 2033
- Table 2: Global Blood Testing Market Volume K Unit Forecast, by Type 2020 & 2033
- Table 3: Global Blood Testing Market Revenue Million Forecast, by Methods 2020 & 2033
- Table 4: Global Blood Testing Market Volume K Unit Forecast, by Methods 2020 & 2033
- Table 5: Global Blood Testing Market Revenue Million Forecast, by End User 2020 & 2033
- Table 6: Global Blood Testing Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 7: Global Blood Testing Market Revenue Million Forecast, by Region 2020 & 2033
- Table 8: Global Blood Testing Market Volume K Unit Forecast, by Region 2020 & 2033
- Table 9: Global Blood Testing Market Revenue Million Forecast, by Type 2020 & 2033
- Table 10: Global Blood Testing Market Volume K Unit Forecast, by Type 2020 & 2033
- Table 11: Global Blood Testing Market Revenue Million Forecast, by Methods 2020 & 2033
- Table 12: Global Blood Testing Market Volume K Unit Forecast, by Methods 2020 & 2033
- Table 13: Global Blood Testing Market Revenue Million Forecast, by End User 2020 & 2033
- Table 14: Global Blood Testing Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 15: Global Blood Testing Market Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Global Blood Testing Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 17: United States Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: United States Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 19: Canada Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 20: Canada Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 21: Mexico Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 22: Mexico Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 23: Global Blood Testing Market Revenue Million Forecast, by Type 2020 & 2033
- Table 24: Global Blood Testing Market Volume K Unit Forecast, by Type 2020 & 2033
- Table 25: Global Blood Testing Market Revenue Million Forecast, by Methods 2020 & 2033
- Table 26: Global Blood Testing Market Volume K Unit Forecast, by Methods 2020 & 2033
- Table 27: Global Blood Testing Market Revenue Million Forecast, by End User 2020 & 2033
- Table 28: Global Blood Testing Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 29: Global Blood Testing Market Revenue Million Forecast, by Country 2020 & 2033
- Table 30: Global Blood Testing Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 31: Germany Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: Germany Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 33: United Kingdom Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 34: United Kingdom Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 35: France Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 36: France Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 37: Italy Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 38: Italy Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 39: Spain Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 40: Spain Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 41: Rest of Europe Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 42: Rest of Europe Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 43: Global Blood Testing Market Revenue Million Forecast, by Type 2020 & 2033
- Table 44: Global Blood Testing Market Volume K Unit Forecast, by Type 2020 & 2033
- Table 45: Global Blood Testing Market Revenue Million Forecast, by Methods 2020 & 2033
- Table 46: Global Blood Testing Market Volume K Unit Forecast, by Methods 2020 & 2033
- Table 47: Global Blood Testing Market Revenue Million Forecast, by End User 2020 & 2033
- Table 48: Global Blood Testing Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 49: Global Blood Testing Market Revenue Million Forecast, by Country 2020 & 2033
- Table 50: Global Blood Testing Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 51: China Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 52: China Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 53: Japan Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 54: Japan Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 55: India Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 56: India Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 57: Australia Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 58: Australia Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 59: South Korea Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 60: South Korea Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 61: Rest of Asia Pacific Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 62: Rest of Asia Pacific Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 63: Global Blood Testing Market Revenue Million Forecast, by Type 2020 & 2033
- Table 64: Global Blood Testing Market Volume K Unit Forecast, by Type 2020 & 2033
- Table 65: Global Blood Testing Market Revenue Million Forecast, by Methods 2020 & 2033
- Table 66: Global Blood Testing Market Volume K Unit Forecast, by Methods 2020 & 2033
- Table 67: Global Blood Testing Market Revenue Million Forecast, by End User 2020 & 2033
- Table 68: Global Blood Testing Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 69: Global Blood Testing Market Revenue Million Forecast, by Country 2020 & 2033
- Table 70: Global Blood Testing Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 71: GCC Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 72: GCC Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 73: South Africa Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 74: South Africa Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 75: Rest of Middle East and Africa Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 76: Rest of Middle East and Africa Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 77: Global Blood Testing Market Revenue Million Forecast, by Type 2020 & 2033
- Table 78: Global Blood Testing Market Volume K Unit Forecast, by Type 2020 & 2033
- Table 79: Global Blood Testing Market Revenue Million Forecast, by Methods 2020 & 2033
- Table 80: Global Blood Testing Market Volume K Unit Forecast, by Methods 2020 & 2033
- Table 81: Global Blood Testing Market Revenue Million Forecast, by End User 2020 & 2033
- Table 82: Global Blood Testing Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 83: Global Blood Testing Market Revenue Million Forecast, by Country 2020 & 2033
- Table 84: Global Blood Testing Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 85: Brazil Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 86: Brazil Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 87: Argentina Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 88: Argentina Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 89: Rest of South America Global Blood Testing Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 90: Rest of South America Global Blood Testing Market Volume (K Unit) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Global Blood Testing Market?
The projected CAGR is approximately 6.88%.
2. Which companies are prominent players in the Global Blood Testing Market?
Key companies in the market include Becton Dickinson and Company, BioMerieux SA, Novartis International AG, Waters Corporation, Una Health Ltd, Abbott Laboratories, Danaher Corporation, F Hoffmann-La Roche AG, BioRad Laboratories, Thermo Fisher Scientific, PerkinElmer Inc , Shimadzu Corporation.
3. What are the main segments of the Global Blood Testing Market?
The market segments include Type, Methods, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 90.62 Million as of 2022.
5. What are some drivers contributing to market growth?
Growing Burden of Chronic Diseases; Rising Demand for Home Healthcare and the Introduction of Advance Technology-enabled Products; Implementation of Favorable Government Initiatives & External Funding for R&D Exercises.
6. What are the notable trends driving market growth?
Glucose Testing is Expected to Hold Significant Share of the Blood Testing Market..
7. Are there any restraints impacting market growth?
Stringent Regulatory Approval Process.
8. Can you provide examples of recent developments in the market?
March 2023: Guardant Health, Inc. submitted to the US Food and Drug Administration (FDA) the final module of its premarket approval (PMA) application for Shield, Guardant Health's blood test to screen for colorectal cancer (CRC).
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Global Blood Testing Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Global Blood Testing Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Global Blood Testing Market?
To stay informed about further developments, trends, and reports in the Global Blood Testing Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence